(Q37362757)

19 August 2017

1 reference

title

Prehypertension: should we be treating with pharmacologic therapy? (English)

1 reference

19 August 2017

1 reference

Brent M Egan

1

1 reference

19 August 2017

Shawna D Nesbitt

series ordinal

2

1 reference

19 August 2017

Stevo Julius

series ordinal

3

1 reference

19 August 2017

language of work or name

1 reference

1 August 2008

1 reference

Therapeutic advances in cardiovascular disease

19 August 2017

published in

1 reference

19 August 2017

volume

2

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

305-314

1 reference

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Expanding the definition and classification of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Borderline hypertension--a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Trial of preventing hypertension: design and 2-year progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Feasibility of treating prehypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

High-normal blood pressure progression to hypertension in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Prehypertension and cardiovascular morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Endothelium-dependent vasodilation in normotensive subjects with a familial history of essential hypertension and in young subjects with borderline hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

A strategy to reduce cardiovascular disease by more than 80%

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

From "prehypertension" to hypertension? Additional evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708094226

21 January 2018

Identifiers

DOI

10.1177/1753944708094226

1 reference

release_ie7xmgh2p5bmrjatmt6z5f6ns4

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ie7xmgh2p5bmrjatmt6z5f6ns4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference